Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amélie Dos santos"'
Autor:
Amélie Dos santos, Edouard Courtin, Aurélie Ruet, Pierre Duffau, Guillaume Mathey, Ines Bekkour, Jonathan Ciron, Laure Michel, François Xavier Blanc, Jésus Aguilar, Pascal Lejeune, Guillaume Marc, David Laplaud, Armelle Magot, Mohamed Hamidou, Sandrine Wiertlewski
Publikováno v:
Brain and Behavior, Vol 14, Iss 9, Pp n/a-n/a (2024)
Abstract Introduction Neurosarcoidosis (NS) is a systemic inflammatory granulomatous disease affecting of patients with sarcoidosis. Its diagnosis is difficult as there is no specific test for it. Because of its rarity, the management of NS has so fa
Externí odkaz:
https://doaj.org/article/67af044b88c24603859f4c1083f1677d
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Background Lyme neuroborreliosis (LNB), due to infection of the nervous system by the spirochete Borrelia burgdorferi, occurs in 15% of Lyme disease cases. However, neurovascular involvement is uncommon, especially recurrent stroke related t
Externí odkaz:
https://doaj.org/article/7840866a6f1a46e08a326c9c7e870ede
Autor:
Amélie Dos Santos, Edouard Courtin, Guillaume Mathey, Jonathan Ciron, Francois Xavier Blanc, Mohamed Hamidou, Sandrine Wiertlewski
Publikováno v:
Revue Neurologique. 179:S144
Autor:
Lila Sirven-Villaros, Sylvain Lamure, Thomas Gastinne, Florent Wallet, Antoine F. Carpentier, Benoit Tessoulin, David Laplaud, Claire Simard, Catherine Belin, Elie Azoulay, Adrien Paix, Catherine Thieblemont, Perrine Devic, Guillaume Cartron, Renata Ursu, Laura Platon, Xavier Ayrignac, Emmanuel Bachy, Colette Berger, Amélie Dos Santos
Publikováno v:
Scientific Reports
Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.91-93. ⟨10.1038/s41598-020-76055-9⟩
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.91-93. ⟨10.1038/s41598-020-76055-9⟩
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Chimeric antigen receptor-modified T (CAR T) cell therapy is a highly promising treatment for haematological malignancies but is frequently associated with cytokine release syndrome and neurotoxicity. Between July 2018 and July 2019, all patients tre
Autor:
Jean-Baptiste Noury, Laure Michel, Julien Cassereau, Sandrine Wiertlewski, Amélie Dos Santos, Clement Baron, Armelle Magot
Publikováno v:
Revue Neurologique. 176:S20
Introduction 15 % des myasthenies auto-immune (MAI) sont refractaires et necessitent un traitement immunosuppresseur de seconde ligne. Plusieurs etudes de cas ont montre l’interet du traitement par Rituximab dans la MAI. Objectifs Notre objectif pr